194 related articles for article (PubMed ID: 34283047)
1. Role of Splicing Regulatory Elements and In Silico Tools Usage in the Identification of Deep Intronic Splicing Variants in Hereditary Breast/Ovarian Cancer Genes.
Moles-Fernández A; Domènech-Vivó J; Tenés A; Balmaña J; Diez O; Gutiérrez-Enríquez S
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283047
[TBL] [Abstract][Full Text] [Related]
2. Comparison of
Jang W; Park J; Chae H; Kim M
Int J Genomics; 2022; 2022():5265686. PubMed ID: 36275637
[TBL] [Abstract][Full Text] [Related]
3. Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations?
Moles-Fernández A; Duran-Lozano L; Montalban G; Bonache S; López-Perolio I; Menéndez M; Santamariña M; Behar R; Blanco A; Carrasco E; López-Fernández A; Stjepanovic N; Balmaña J; Capellá G; Pineda M; Vega A; Lázaro C; de la Hoya M; Diez O; Gutiérrez-Enríquez S
Front Genet; 2018; 9():366. PubMed ID: 30233647
[No Abstract] [Full Text] [Related]
4. Screening of
Montalban G; Bonache S; Moles-Fernández A; Gisbert-Beamud A; Tenés A; Bach V; Carrasco E; López-Fernández A; Stjepanovic N; Balmaña J; Diez O; Gutiérrez-Enríquez S
J Med Genet; 2019 Feb; 56(2):63-74. PubMed ID: 30472649
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.
Keegan NP; Wilton SD; Fletcher S
Front Genet; 2021; 12():806946. PubMed ID: 35140743
[TBL] [Abstract][Full Text] [Related]
6. Identification of Spliceogenic Variants beyond Canonical GT-AG Splice Sites in Hereditary Cancer Genes.
Dragoš VŠ; Strojnik K; Klančar G; Škerl P; Stegel V; Blatnik A; Banjac M; Krajc M; Novaković S
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806449
[TBL] [Abstract][Full Text] [Related]
7. Computational prediction of human deep intronic variation.
Barbosa P; Savisaar R; Carmo-Fonseca M; Fonseca A
Gigascience; 2022 Dec; 12():. PubMed ID: 37878682
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of splicing defects in selected primary immunodeficiencies-related genes.
Grodecká L; Hujová P; Kramárek M; Kršjaková T; Kováčová T; Vondrášková K; Ravčuková B; Hrnčířová K; Souček P; Freiberger T
Clin Immunol; 2017 Jul; 180():33-44. PubMed ID: 28359783
[TBL] [Abstract][Full Text] [Related]
9. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
Petersen USS; Doktor TK; Andresen BS
Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
[TBL] [Abstract][Full Text] [Related]
10. Variant effect on splicing regulatory elements, branchpoint usage, and pseudoexonization: Strategies to enhance bioinformatic prediction using hereditary cancer genes as exemplars.
Canson D; Glubb D; Spurdle AB
Hum Mutat; 2020 Oct; 41(10):1705-1721. PubMed ID: 32623769
[TBL] [Abstract][Full Text] [Related]
11. SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing.
Leman R; Parfait B; Vidaud D; Girodon E; Pacot L; Le Gac G; Ka C; Ferec C; Fichou Y; Quesnelle C; Aucouturier C; Muller E; Vaur D; Castera L; Boulouard F; Ricou A; Tubeuf H; Soukarieh O; Gaildrat P; Riant F; Guillaud-Bataille M; Caputo SM; Caux-Moncoutier V; Boutry-Kryza N; Bonnet-Dorion F; Schultz I; Rossing M; Quenez O; Goldenberg L; Harter V; Parsons MT; Spurdle AB; Frébourg T; Martins A; Houdayer C; Krieger S
Hum Mutat; 2022 Dec; 43(12):2308-2323. PubMed ID: 36273432
[TBL] [Abstract][Full Text] [Related]
12. Identification of Deep-Intronic Splice Mutations in a Large Cohort of Patients With Inherited Retinal Diseases.
Qian X; Wang J; Wang M; Igelman AD; Jones KD; Li Y; Wang K; Goetz KE; Birch DG; Yang P; Pennesi ME; Chen R
Front Genet; 2021; 12():647400. PubMed ID: 33737949
[TBL] [Abstract][Full Text] [Related]
13. Toward a clinical diagnostic pipeline for SPINK1 intronic variants.
Tang XY; Lin JH; Zou WB; Masson E; Boulling A; Deng SJ; Cooper DN; Liao Z; Férec C; Li ZS; Chen JM
Hum Genomics; 2019 Feb; 13(1):8. PubMed ID: 30755276
[TBL] [Abstract][Full Text] [Related]
14. Mis-splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays.
Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Goina E; Acedo A; Buratti E; Velasco EA
J Pathol; 2019 Aug; 248(4):409-420. PubMed ID: 30883759
[TBL] [Abstract][Full Text] [Related]
15. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
Ryu JS; Lee HY; Cho EH; Yoon KA; Kim MK; Joo J; Lee ES; Kang HS; Lee S; Lee DO; Lim MC; Kong SY
Cancer Sci; 2020 Oct; 111(10):3912-3925. PubMed ID: 32761968
[TBL] [Abstract][Full Text] [Related]
16. Mutations of Pre-mRNA Splicing Regulatory Elements: Are Predictions Moving Forward to Clinical Diagnostics?
Grodecká L; Buratti E; Freiberger T
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758972
[TBL] [Abstract][Full Text] [Related]
17. Benchmarking deep learning splice prediction tools using functional splice assays.
Riepe TV; Khan M; Roosing S; Cremers FPM; 't Hoen PAC
Hum Mutat; 2021 Jul; 42(7):799-810. PubMed ID: 33942434
[TBL] [Abstract][Full Text] [Related]
18. Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity.
Hirschi OR; Felker SA; Rednam SP; Vallance KL; Parsons DW; Roy A; Cooper GM; Plon SE
medRxiv; 2023 Nov; ():. PubMed ID: 37961416
[TBL] [Abstract][Full Text] [Related]
19. Rules and tools to predict the splicing effects of exonic and intronic mutations.
Ohno K; Takeda JI; Masuda A
Wiley Interdiscip Rev RNA; 2018 Jan; 9(1):. PubMed ID: 28949076
[TBL] [Abstract][Full Text] [Related]
20. Minigene Splicing Assays Identify 12 Spliceogenic Variants of
Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Caloca MJ; Gómez-Barrero S; Velasco EA
Front Genet; 2019; 10():503. PubMed ID: 31191615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
